World News

European Pharmaceuticals Fined $195 Million

TEXT SIZE - +
European Union anti-trust regulators have fined a Danish pharmaceutical company and a group of generic drugmakers for colluding to delay bringing to market the generic form of a popular anti-depressant.

Denmark's Lundbeck was fined $125 million, while the generic drug producers were fined $70 million.

Lundbeck was accused of paying the other companies to delay delivery of a generic version of Lundbeck's anti-depressant medicine citalopram.

Generic drugs usually cost a fraction of the original medicine.

EU Competition Commissioner Joaquin Almunia said pay-to-delay agreements "directly harm patients and national health systems which are already under tight budgetary constraints." He said the commission will not tolerate "anticompetitive practices."

Lundbeck says it intends to appeal the decision.

Feature Story

Ukrainian security force officers are deployed at a checkpoint set on fire and left by pro-Russian separatists near Slaviansk, April 24, 2014.

Multimedia Ukraine Forces Kill Up to 5 Rebels in Slovyansk

Russian President Vladimir Putin warns of 'consequences' if Kyiv used army against 'its own people' More